We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$37M
1-Year Est. Return
63.54%
This Fund
S&P 500
This Quarter
Est. Return
-22.77%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,089.98%
AUM
$1.72B
AUM Growth
-$1.36B
(-44%)
Cap. Flow
-$888M
Cap. Flow
% of AUM
-51.56%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
299
New
73
Increased
48
Reduced
40
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Glaukos
GKOS
|
+$37.8M |
| 2 |
Guardant Health
GH
|
+$19.9M |
| 3 |
Pulmonx
LUNG
|
+$15.2M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$13.5M |
| 5 |
LYRA
LYRA THERAPEUTICS INC
LYRA
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$18M |
| 2 |
C4 Therapeutics
CCCC
|
+$15.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$13.5M |
| 4 |
ICU Medical
ICUI
|
+$12.8M |
| 5 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.95% |
| 2 | Industrials | 0.3% |
| 3 | Consumer Staples | 0.27% |
| 4 | Materials | 0.11% |
| 5 | Financials | 0% |
Similar funds
CI
RH
ICP
GC
BAM
CM
AP
ACM
Pura Vida Investments's Q2 2022 Portfolio in Review
As of Q2 2022, Pura Vida Investments held 299 positions worth $1.72B, down 44% from $3.08B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Pura Vida Investments withdrew a net $888M in Q2 2022, closing 96 positions and reducing 40 holdings. Its most notable exit was C4 Therapeutics, an estimated $15.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Pura Vida Investments opened a new position in Glaukos worth $36.2M.
- Pura Vida Investments's largest Q2 2022 buy was Glaukos: 796,600 shares worth $36.2M.
- Pura Vida Investments added most to Guardant Health in Q2 2022, an estimated $19.9M increase.
- Pura Vida Investments's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $18M.
- Pura Vida Investments fully exited C4 Therapeutics in Q2 2022, selling an estimated $15.2M.
- Pura Vida Investments's ten largest holdings make up 33% of its $1.72B portfolio in Q2 2022.
- Pura Vida Investments opened 73 new positions and closed 96 in Q2 2022.
- Pura Vida Investments's portfolio value fell 44% quarter-over-quarter to $1.72B.
Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.